IRIS
LOPETUSO, Loris Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.408
AS - Asia 2.688
EU - Europa 2.269
SA - Sud America 571
Continente sconosciuto - Info sul continente non disponibili 521
AF - Africa 58
OC - Oceania 12
Totale 12.527
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.250
SG - Singapore 1.451
IT - Italia 548
IE - Irlanda 482
RU - Federazione Russa 465
BR - Brasile 421
CN - Cina 382
VN - Vietnam 332
SE - Svezia 274
DE - Germania 123
BD - Bangladesh 105
HK - Hong Kong 105
GB - Regno Unito 87
CA - Canada 79
AR - Argentina 57
IN - India 49
JP - Giappone 40
NL - Olanda 37
AT - Austria 35
MX - Messico 35
FR - Francia 33
ID - Indonesia 30
EC - Ecuador 28
CO - Colombia 25
ES - Italia 25
IQ - Iraq 24
PL - Polonia 23
FI - Finlandia 21
TR - Turchia 18
TW - Taiwan 18
BE - Belgio 17
PK - Pakistan 17
RO - Romania 17
ZA - Sudafrica 17
UA - Ucraina 15
IR - Iran 14
SA - Arabia Saudita 13
PH - Filippine 12
TH - Thailandia 12
AU - Australia 11
BG - Bulgaria 11
HR - Croazia 11
MY - Malesia 11
VE - Venezuela 11
CR - Costa Rica 10
EG - Egitto 10
KR - Corea 9
PE - Perù 9
CL - Cile 8
NP - Nepal 8
CH - Svizzera 7
JM - Giamaica 7
UZ - Uzbekistan 7
LU - Lussemburgo 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
EU - Europa 5
HN - Honduras 5
PA - Panama 5
DZ - Algeria 4
LT - Lituania 4
PY - Paraguay 4
RS - Serbia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BH - Bahrain 3
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
MA - Marocco 3
QA - Qatar 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
ME - Montenegro 2
MQ - Martinica 2
NG - Nigeria 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
SC - Seychelles 2
TZ - Tanzania 2
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 11.997
Salva come PNG Salva come JPEG
Città #
Singapore 954
Chandler 766
San Jose 603
Dublin 481
Ashburn 434
Dallas 279
Princeton 235
Council Bluffs 220
Jacksonville 191
Santa Clara 125
Los Angeles 118
Altamura 114
Beijing 104
Hong Kong 94
Dong Ket 93
Ho Chi Minh City 93
Wilmington 86
Redondo Beach 66
New York 64
Ann Arbor 57
Rome 57
Buffalo 55
Hanoi 55
Moscow 50
Atlanta 46
Chieti 43
The Dalles 42
Nuremberg 35
São Paulo 35
Frankfurt am Main 33
Tokyo 31
Orem 30
Pescara 30
Falls Church 27
Chicago 25
Montreal 25
Columbus 24
Memphis 24
Munich 23
London 22
San Francisco 22
Taranto 20
Phoenix 19
Denver 18
Brussels 17
Norwalk 17
Milan 16
Rio de Janeiro 16
Teramo 16
Stockholm 14
Hefei 13
Houston 12
Pune 12
Amsterdam 11
Brooklyn 11
Guangzhou 11
Toronto 11
Vienna 11
Xitun 11
Baghdad 10
Boardman 10
Bologna 10
Cluj-Napoca 10
Manchester 10
Mexico City 10
Sofia 10
Tongling 10
Brasília 9
Curitiba 9
Edinburgh 9
Guayaquil 9
Helsinki 9
Palermo 9
Warsaw 9
Belo Horizonte 8
Calgary 8
Da Nang 8
Dhaka 8
Las Vegas 8
Naples 8
San José 8
Washington 8
Zagreb 8
Bari 7
Johannesburg 7
Lappeenranta 7
Macerata 7
Porto Alegre 7
Quito 7
Tashkent 7
Ankara 6
Biên Hòa 6
Chennai 6
Guglionesi 6
Haiphong 6
Jakarta 6
Kingston 6
Kuala Lumpur 6
Lima 6
Salvador 6
Totale 6.491
Salva come PNG Salva come JPEG
Nome #
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 963
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus 417
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 298
Role of Helicobacter pylori infection on nutrition and metabolism 195
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): Preliminary results from a retrospective cohort study 193
Assessment of crohn’s disease activity: Magnetic resonance enterography in comparison with clinical and endoscopic evaluations 158
13C-octanoic acid breath test to study gastric emptying time 145
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 144
The use of anti-spasmodics in the treatment of irritable bowel syndrome: Focus on otilonium bromide 143
Bacillus clausii and gut homeostasis: state of the art and future perspectives 132
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 123
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD? 117
Akkermansia muciniphila: Key player in metabolic and gastrointestinal disorders 117
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 114
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 112
Characterization of sarcopenia in an IBD population attending an Italian gastroenterology tertiary center 110
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 109
Interleukin 1β Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor-Independent Ulcerative Colitis 107
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 103
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 103
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 103
A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis 102
Actinobacteria: A relevant minority for the maintenance of gut homeostasis 101
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 100
Coordinated Multi-Language Translation of A Validated Symptom Questionnaire for Carbohydrate Intolerances: A Practical Structured Procedure 99
Proteobacteria: A common factor in human diseases 99
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 99
Beyond the HLA Genes in Gluten-Related Disorders 99
Diagnosis of Cholangiocarcinoma: The New Biological and Technological Horizons 98
Role of yeasts in healthy and impaired gut microbiota: The gut mycome 98
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment 97
Food components and dietary habits: Keys for a healthy gut microbiota composition 96
Assessment of neurological manifestations in hospitalized patients with COVID-19 96
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 94
The gastrointestinal microbiome - Functional interference between stomach and intestine 93
Flexible colonoscopy in mice to evaluate the severity of colitis and colorectal tumors using a validated endoscopic scoring system 91
Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis 91
Opposing functions of classic and novel IL-1 family members in gut health and disease 88
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: A multidisciplinary management experience 87
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 87
Bacteriocins and bacteriophages: Therapeutic weapons for gastrointestinal diseases? 87
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 87
Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases 87
The gut barrier: New acquisitions and therapeutic approaches 86
Ulcerative colitis 86
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises from a First Meta-Analysis 86
Locally injected Infliximab ameliorates murine DSS colitis: Differences in serum and intestinal levels of drug between healthy and colitic mice 85
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 84
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 84
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center 84
Commensal Clostridia: Leading players in the maintenance of gut homeostasis 83
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 82
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 82
Gut microbiota modulation and mucosal immunity: Focus on Rifaximin 81
European Crohn's and colitis organisation topical review on treatment withdrawal ['exit strategies'] in inflammatory bowel disease 81
Unfolded protein response: An essential element of intestinal homeostasis and a potential therapeutic target for inflammatory bowel disease 80
The innate and adaptive immune system as targets for biologic therapies in inflammatory bowel disease 80
Commentary to “safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease” 79
Microbiota and inflammatory bowel disease: An update 79
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 79
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 79
Gut Virome and Inflammatory Bowel Disease 78
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 78
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 78
Can we predict the efficacy of anti-TNF-α agents? 77
Gut microbiota and inflammatory bowel disease: So far so gut! 76
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders 76
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 76
Dietary magnesium alleviates experimental murine colitis through upregulation of the transient receptor potential melastatin 6 channel 76
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 76
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. Pylori infection 75
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 75
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 75
Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: A case report and review of the literature 74
The therapeutic management of gut barrier leaking: The emerging role for mucosal barrier protectors 74
Intestinal permeability in physiological and pathological conditions: Major determinants and assessment modalities 73
Epidemiological evaluation of acute gastroenteritis and therapeutic approaches in Middle East Countries 73
Coeliac disease under a microscope: Histological diagnostic features and confounding factors 73
Prevalence of severe irritable bowel syndrome among Italian adults. A meta-analysis 72
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 72
When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach 71
The interplay between gut microbiota and the unfolded protein response: Implications for intestinal homeostasis preservation and dysbiosis-related diseases 71
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: Where we stand and future perspectives 71
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 71
Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea 71
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 71
Bariatric procedures and microbiota: patient selection and outcome prediction 71
Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1α and Microbiota's Crosstalk 70
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 70
Considering gut microbiota disturbance in the management of Helicobacter pylori infection 69
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study 69
Predicting In-Hospital Mortality in COVID-19 Older Patients with Specifically Developed Scores 69
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study 68
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 68
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 68
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 67
Relationship between oral microbiota and periodontal disease: A systematic review 67
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications 67
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 66
Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis 66
Totale 10.370
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.311
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022649 0 0 3 118 20 16 11 28 54 39 60 300
2022/20231.882 241 337 89 224 95 348 120 143 169 18 81 17
2023/2024849 53 36 47 51 36 186 235 87 14 37 13 54
2024/20251.774 158 348 191 54 36 112 82 96 305 84 163 145
2025/20264.521 257 152 583 463 382 167 699 287 564 413 397 157
2026/20272.014 1.107 783 124 0 0 0 0 0 0 0 0 0
Totale 12.527